Fertile
Bluelighter
- Joined
- Mar 31, 2022
- Messages
- 1,627
Series: Journal of Child Neurology 2019-jun 19 vol. 34 iss. 12
Author(s): Gedela, Sravya; Gedela, Satyanarayana; Glynn, Peter; Salvator, Ann; Patel, Anup D.
doi: 10.1177/0883073819856834
I'm sure people can locate this paper.
In children clobazam doses are generally up to 1mg/kg/day or 40mg (whichever is the lower).
The key finding for most people is 'supratherapeutic doses of clobazam were well tolerated, without an increased reporting of side effects compared to patients receiving doses that are in the normal therapeutic range as recommended by the FDA. Therefore, patients who do require higher doses can be counseled that the likelihood of side effects may not increase with elevated dosing. Interestingly, patients in our study receiving higher doses of clobazam did not appear to have greater benefit in seizure reduction when compared to normal dose ranges of clobazam.'
What this says is that my inference that clobazam (and almost certainly ALL 1,5-benzodiazepines) have a dose-response curve that plateaus at around 40mg/day. I believe this is because at that dose the α2 subunit that clobazam is (fairly) selective for has almost 100% occupancy.
In short, it seems almost impossible to overdose on clobazam alone. Mixed with other CNS depressants is obviously still a very risky thing to do.
I believe it's key to ensure that clobazam is not brought under the FDAs increasingly strong legal controls. In fact it is my belief that it does not produce a notable abstinence syndrome and could safely be sold as a non-prescription medicine.
Author(s): Gedela, Sravya; Gedela, Satyanarayana; Glynn, Peter; Salvator, Ann; Patel, Anup D.
doi: 10.1177/0883073819856834
I'm sure people can locate this paper.
In children clobazam doses are generally up to 1mg/kg/day or 40mg (whichever is the lower).
The key finding for most people is 'supratherapeutic doses of clobazam were well tolerated, without an increased reporting of side effects compared to patients receiving doses that are in the normal therapeutic range as recommended by the FDA. Therefore, patients who do require higher doses can be counseled that the likelihood of side effects may not increase with elevated dosing. Interestingly, patients in our study receiving higher doses of clobazam did not appear to have greater benefit in seizure reduction when compared to normal dose ranges of clobazam.'
What this says is that my inference that clobazam (and almost certainly ALL 1,5-benzodiazepines) have a dose-response curve that plateaus at around 40mg/day. I believe this is because at that dose the α2 subunit that clobazam is (fairly) selective for has almost 100% occupancy.
In short, it seems almost impossible to overdose on clobazam alone. Mixed with other CNS depressants is obviously still a very risky thing to do.
I believe it's key to ensure that clobazam is not brought under the FDAs increasingly strong legal controls. In fact it is my belief that it does not produce a notable abstinence syndrome and could safely be sold as a non-prescription medicine.
Last edited: